2016 International Congress Archives - Page 44 of 207

12:00pm-1:30pm: STEADY-PD III. A phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease. Baseline characteristics of the enrolled cohort

T. Simuni, K.M. Biglan, J. Lowell, K. Hodgeman, B. Greco, R. Rockhill, D. Oakes (Chicago, IL, USA)

Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Stiff person syndrome

P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Stiff person syndrome: Case series

E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: STN-DBS in Parkinson’s disease with early motor complications – A 10 year follow-up

J. Muellner, F. Pineau, D. Maltête, J.L. Houeto, M.L. Welter, S. Navarro, P. Cornu, C. Bernasconi, Y. Agid, M. Schuepbach (Bern, Switzerland)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Strategies to improve drug development efficiency through regulatory interactions, minimizing the placebo effect and improving data integrity within a phase 3 study of tozadenant in Parkinson’s disease patients with motor fluctuations (TOZ-PD)

F. Kerwood, C. Kenney, K. Kieburtz, W. Olanow, C. Resburg, J. Krishnaswami, S. Bandak (San Francisco, CA, USA)

Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Striatal and pedunculopontine nucleus diffusion tensor imaging in cervical dystonia

K. Mente, A. Holmes, D. Urbano, M. Hallett, S.G. Horovitz (Bethesda, MD, USA)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Striatal postsynaptic dysfunction in X-linked dystonia-parkinsonism is associated with disease progression

N. Brüggemann, R.L. Rosales, J.L. Waugh, A.J. Blood, A. Domingo, M. Heldmann, R.D. Jamora, A. Münchau, L.V. Lee, I. Buchmann, C. Klein (Lübeck, Germany)

Dystonia and Pediatric Movement Disorders

12:00pm-1:30pm: STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm

C.V. Chirumamilla, G. Deuschl, K.E. Zeuner, M. Muthuraman, S. Groppa (Mainz, Germany)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Structural and functional brain network alterations in psychogenic dystonia

E. Sarasso, F. Agosta, A. Tomic, S. Basaia, M. Svetel, G. Mandic-Stojmenovic, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

Dystonia and Pediatric Movement Disorders